ClinicalTrials.gg
RecruitingNCT07767591AIS-SLEEPUpdated Oct 20, 2026

Sleep Quality in Adolescents With Idiopathic Scoliosis

An observational study in Adolescent, Scoliosis and Adolescent Idiopathic Scoliosis (AIS), sponsored by Bezmialem Vakif University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 10 Years to 19 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Bezmialem Vakif University · Observational

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Updated Oct 20, 2026Now RecruitingFirst site in Turkey (Türkiye)+1 moreGo to Updates ↓
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
100
Ages
10 Years to 19 Years
Sex
All
01

Study summary

This controlled cross-sectional observational study aims to compare sleep quality between adolescents with idiopathic scoliosis and age- and sex-similar healthy controls. Participants aged 10-18 years will complete online questionnaires assessing demographic characteristics and sleep quality. Adolescents with idiopathic scoliosis will also be evaluated for scoliosis-specific quality of life, body image, Cobb angle, curve type, pain, brace use, and daily brace-wearing duration. The study will additionally investigate factors associated with sleep quality in the scoliosis group. The planned enrollment is 100 participants, including 50 adolescents with idiopathic scoliosis and 50 healthy controls.

Read the detailed description

This controlled cross-sectional observational study is designed to evaluate sleep quality in adolescents with idiopathic scoliosis (AIS) and to compare their sleep quality with that of age- and sex-similar healthy controls. The study will include participants aged 10-18 years and will enroll approximately 100 individuals, consisting of 50 adolescents with AIS and 50 healthy controls.

Data will be collected online using Google Forms. All participants will complete a demographic information form and the Pittsburgh Sleep Quality Index (PSQI). The demographic form will include information on age, sex, height, weight, screen time, physical activity level, sleep duration, sleep environment, and sleep habits.

Participants in the AIS group will additionally complete the Scoliosis Research Society-22 Questionnaire (SRS-22). Clinical information specific to scoliosis, including Cobb angle, curve type, pain, brace use, and daily brace-wearing duration, will also be recorded. Cobb angle and curve type will be obtained from available medical records or the most recent radiological evaluation report.

The primary analysis will compare sleep quality between the AIS and healthy control groups. Secondary analyses will investigate relationships between PSQI total score and scoliosis-related, psychosocial, and treatment-related factors, including Cobb angle, pain, scoliosis-specific quality of life, brace use, and daily brace-wearing duration. Correlation analyses and multiple linear regression will be used to identify factors independently associated with sleep quality within the AIS group.

No intervention, medication, radiological imaging, or physical examination will be performed as part of the study. Participation will consist of completing the online questionnaires, while relevant scoliosis-related clinical data will be verified from existing medical records.

02

Conditions studied

  • Adolescent
  • Scoliosis
  • Adolescent Idiopathic Scoliosis (AIS)

Keywords

  • scoliosis
  • adolescent
  • sleep quality
03

In context

Scoliosis

660 studies on the registry are indexed under Scoliosis; 186 are open to participants now.

This study's planned enrollment of 100 is above the median of 84 across 256 observational studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

Bezmialem Vakif University is the lead sponsor of 354 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of adolescents aged 10-19 years with adolescent idiopathic scoliosis who were previously referred from the Orthopedics and Traumatology Outpatient Clinic to the Orthopedic Training and Research Laboratory, and age- and sex-similar healthy adolescents without known scoliosis or another spinal deformity. Data are collected online from eligible volunteers using Google Forms. Clinical scoliosis-related information is verified from available medical records and radiological reports.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion Criteria for the Adolescent Idiopathic Scoliosis Group:

  • Aged 10-19 years
  • Diagnosed with adolescent idiopathic scoliosis by a specialist physician
  • Able to read and understand Turkish
  • Willing to participate voluntarily

Exclusion Criteria for the Adolescent Idiopathic Scoliosis Group:

  • Having a type of scoliosis other than adolescent idiopathic scoliosis
  • Previous spinal surgery
  • Presence of a neurological, rheumatological, cardiovascular, or psychiatric condition that may prevent participation in the study

Inclusion criteria

Inclusion Criteria for the Healthy Control Group:

  • Aged 10-19 years
  • No known scoliosis or other spinal deformity
  • Able to read and understand Turkish
  • Willing to participate voluntarily

Exclusion criteria

Exclusion Criteria for the Healthy Control Group:

  • Presence of a neurological, rheumatological, cardiovascular, or psychiatric condition that may prevent participation in the study
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Adolescents With Idiopathic Scoliosis

    Adolescents aged 10-18 years with a diagnosis of adolescent idiopathic scoliosis. Participants complete a demographic information form, the Pittsburgh Sleep Quality Index, and the Scoliosis Research Society-22 Questionnaire. Scoliosis-related clinical data, including Cobb angle, curve type, pain, brace use, and daily brace-wearing duration, are also recorded. No intervention is assigned.

  • Healthy Controls

    Age- and sex-similar healthy adolescents aged 10-18 years without known scoliosis or another spinal deformity. Participants complete a demographic information form and the Pittsburgh Sleep Quality Index. No intervention is assigned.

06

What researchers measure

Primary outcomes

  1. Sleep Quality Assessed by the Pittsburgh Sleep Quality Index

    Sleep quality during the previous month will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The PSQI global score ranges from 0 to 21 points, with higher scores indicating poorer sleep quality. The primary comparison will be the difference in PSQI global scores between adolescents with idiopathic scoliosis and age- and sex-similar healthy controls.

    Time frame: At study enrollment (single cross-sectional assessment)

Secondary outcomes

  1. Correlation Coefficient Between Sleep Quality and Cobb Angle

    The correlation between sleep quality and scoliosis curve magnitude will be evaluated in participants with adolescent idiopathic scoliosis using the Pittsburgh Sleep Quality Index (PSQI) global score and Cobb angle. The PSQI global score ranges from 0 to 21 points, with higher scores indicating poorer sleep quality. Cobb angle will be obtained from the most recent available radiological evaluation and recorded in degrees. The reported outcome will be the Pearson or Spearman correlation coefficient, as appropriate, ranging from -1 to +1.

    Time frame: At study enrollment (single cross-sectional assessment)

  2. Correlation Coefficient Between Sleep Quality and SRS-22 Function/Activity Domain Score

    The correlation between sleep quality and physical function will be evaluated in participants with adolescent idiopathic scoliosis using the Pittsburgh Sleep Quality Index (PSQI) global score and the function/activity domain score of the Scoliosis Research Society-22 Questionnaire (SRS-22). The PSQI global score ranges from 0 to 21, with higher scores indicating poorer sleep quality. The SRS-22 function/activity domain score ranges from 1 to 5, with higher scores indicating better function. The relationship will be reported as a Pearson or Spearman correlation coefficient, as appropriate, ranging from -1 to +1.

    Time frame: At study enrollment (single cross-sectional assessment)

  3. Correlation Coefficient Between Sleep Quality and SRS-22 Pain Domain Score

    The correlation between sleep quality and pain will be evaluated in participants with adolescent idiopathic scoliosis using the Pittsburgh Sleep Quality Index (PSQI) global score and the pain domain score of the Scoliosis Research Society-22 Questionnaire (SRS-22). The PSQI global score ranges from 0 to 21, with higher scores indicating poorer sleep quality. The SRS-22 pain domain score ranges from 1 to 5, with higher scores indicating less pain and a better health status. The relationship will be reported as a Pearson or Spearman correlation coefficient, as appropriate, ranging from -1 to +1.

    Time frame: At study enrollment (single cross-sectional assessment)

  4. Correlation Coefficient Between Sleep Quality and SRS-22 Self-Image/Appearance Domain Score

    The correlation between sleep quality and self-image/appearance will be evaluated in participants with adolescent idiopathic scoliosis using the Pittsburgh Sleep Quality Index (PSQI) global score and the self-image/appearance domain score of the Scoliosis Research Society-22 Questionnaire (SRS-22). The PSQI global score ranges from 0 to 21, with higher scores indicating poorer sleep quality. The SRS-22 self-image/appearance domain score ranges from 1 to 5, with higher scores indicating a better perception of self-image and appearance. The relationship will be reported as a Pearson or Spearman correlation coefficient, as appropriate, ranging from -1 to +1.

    Time frame: At study enrollment (single cross-sectional assessment)

  5. Correlation Coefficient Between Sleep Quality and SRS-22 Mental Health Domain Score

    The correlation between sleep quality and mental health will be evaluated in participants with adolescent idiopathic scoliosis using the Pittsburgh Sleep Quality Index (PSQI) global score and the mental health domain score of the Scoliosis Research Society-22 Questionnaire (SRS-22). The PSQI global score ranges from 0 to 21, with higher scores indicating poorer sleep quality. The SRS-22 mental health domain score ranges from 1 to 5, with higher scores indicating better mental health. The relationship will be reported as a Pearson or Spearman correlation coefficient, as appropriate, ranging from -1 to +1.

    Time frame: At study enrollment (single cross-sectional assessment)

  6. Pittsburgh Sleep Quality Index Global Score by Brace Use Status

    Sleep quality will be evaluated according to brace use status in participants with adolescent idiopathic scoliosis using the Pittsburgh Sleep Quality Index (PSQI). The PSQI global score ranges from 0 to 21 points, with higher scores indicating poorer sleep quality. The reported outcome will be the PSQI global score in brace users and non-users.

    Time frame: At study enrollment (single cross-sectional assessment)

  7. Pittsburgh Sleep Quality Index Global Score by Daily Brace-Wearing Duration

    Among participants with adolescent idiopathic scoliosis who use a brace, sleep quality will be evaluated according to daily brace-wearing duration. Daily brace-wearing duration will be categorized as less than 8 hours, 8-12 hours, 12-16 hours, 16-20 hours, or more than 20 hours per day. Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI), which has a global score ranging from 0 to 21 points, with higher scores indicating poorer sleep quality. The reported outcome will be the PSQI global score within each brace-wearing duration category.

    Time frame: At study enrollment (single cross-sectional assessment)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2026 (actual). Primary completion is estimated for Dec 2026, 3 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 5, 2026
First posted
Aug 17, 2026
StartActual
Aug 7, 2026
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 25, 2026
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 20, 2026
Sites
1 site added — first site in Turkey (Türkiye)
Show site
  • Bezmialem Vakif University · Istanbul, Turkey (Türkiye)
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Turkey (Türkiye)
    Show site
    • Bezmialem Vakif University · Istanbul, Turkey (Türkiye)
    + 1 other change: date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07767591
Responsible party
Ayşe Sena Manzak (Assitant prof. PT, PhD, Bezmialem Vakif University) — Principal investigator
First posted
Aug 17, 2026
Start date
Aug 7, 2026
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 25, 2026 (estimated)
Last update
Oct 20, 2026

Study contacts

Ayşe Sena Manzak Dursun, PT, PhD
Contact
amanzak@bezmialem.edu.tr
+905356735150
Ayşe Sena Manzak Dursun
principal investigator · Bezmialem Vakif University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion